학술논문

Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase II trial with a long-term follow-up
Document Type
Article
Source
In Annals of Oncology February 2011 22(2):452-457
Subject
Language
ISSN
0923-7534